Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial

1. Garcia-Manero, G.
2. Mufti, G.J.
3. Fenaux, P.
4. Buckstein, R.
5. Santini, V.
6. Díez-Campelo, M.
7. Finelli, C.
8. Ilhan, O.
9. Sekeres, M.A.
10. Zeidan, A.M.
11. Ito, R.
12. Zhang, J.
13. Rampersad, A.
14. Sinsimer, D.
15. Backstrom, J.T.
16. Platzbecker, U.
17. Komrokji, R.S.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1182/BLOOD.2021012589 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus